Publication Detail
The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Cerebrospinal fluid biomarkers in mild cognitive impairment and dementia.
Joshua A Sonnen; Kathleen S Montine; Joseph F Quinn; John C S Breitner; Thomas J Montine (Profiled Author: Breitner, John C S)
Department of Pathology, Division of Neuropathology, University of Washington, Seattle, WA 98104-2420, USA. jsonnen@u.washington.edu
Journal of Alzheimer's disease : JAD 2010;19(1):301-9.
Given the magnitude of the public health problem of dementia in the elderly, there is a pressing need for research, development, and timely application of biomarkers that will identify latent and prodromal illness as well as dementia. Although identification of risk factors and neuroimaging measures will remain key to these efforts, this review focuses on recent progress in the discovery, validation, and standardization of cerebrospinal fluid (CSF) biomarkers, small molecules and macromolecules whose CSF concentration can aid in diagnosis at different stages of disease as well as in assessment of disease progression and response to therapeutics. A multimodal approach that brings independent information from risk factor assessment, neuroimaging, and biomarkers may soon guide physicians in the early diagnosis and management of cognitive impairment in the elderly.
1 Originating Grant
-
1.
KAYE, JEFFREY A
Oregon Alzheimer's Disease Center
1 January 1997 - 31 March 2015
NATIONAL INSTITUTE ON AGING
Total Funding: $ 19,294,037
Scientific Context
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Related Grants
-
1.
GANDY, SAMUEL E
Phase 11-Grape Seed Extract as Anti-Oligomerization Agent in Alzheimer's Disease
15 September 2010 - 30 June 2014
NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE
Total Funding: $ 241,601
-
2.
Cummings, Jeffrey L
Dementia and Disability in Thai Elderly
15 July 2003 - 30 June 2007
FOGARTY INTERNATIONAL CENTER
Total Funding: $ 104,579
-
3.
Knopman, David S
Frontotemporal degeneration: a basis for clinical trials
30 September 2003 - 31 August 2007
NATIONAL INSTITUTE ON AGING
Total Funding: $ 1,649,076
Related Publications
-
1.
2007Anja H Simonsen; James McGuire; Oskar Hansson; Henrik Zetterberg; Vladimir N Podust; Huw A Davies; Gunhild Waldemar; Lennart Minthon; Kaj Blennow
Archives of neurology 2007;64(3):366-70. -
2.
2003Niels Andreasen; Eugeen Vanmechelen; Hugo Vanderstichele; Pia Davidsson; Kaj Blennow
Acta neurologica Scandinavica. Supplementum 2003;179():47-51. -
3.
2008Piotr Lewczuk; Johannes Kornhuber; Hugo Vanderstichele; Eugeen Vanmechelen; Hermann Esselmann; Mirko Bibl; Stefanie Wolf; Markus Otto; Udo Reulbach; Heike Kölsch; et al.
Neurobiology of aging 2008;29(6):812-8.

Appears in this Publication








